Published in Appl Environ Microbiol on December 01, 1996
Enterolysin A, a cell wall-degrading bacteriocin from Enterococcus faecalis LMG 2333. Appl Environ Microbiol (2003) 1.28
Identification and characterization of a lysis module present in a large proportion of bacteriophages infecting Streptococcus thermophilus. Appl Environ Microbiol (1999) 0.99
Bacteriocins of lactic acid bacteria: extending the family. Appl Microbiol Biotechnol (2016) 0.96
Use of 4-sulfophenyl isothiocyanate labeling and mass spectrometry to determine the site of action of the streptococcolytic peptidoglycan hydrolase zoocin A. Appl Environ Microbiol (2008) 0.89
Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061. Appl Environ Microbiol (2000) 0.88
A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia. Antimicrob Agents Chemother (2014) 0.86
Characterization of a novel family of fibronectin-binding proteins with M23 peptidase domains from Treponema denticola. Mol Oral Microbiol (2010) 0.84
Sharpening Host Defenses during Infection: Proteases Cut to the Chase. Mol Cell Proteomics (2017) 0.78
Prediction of peptidoglycan hydrolases- a new class of antibacterial proteins. BMC Genomics (2016) 0.76
The metal binding site of zoocin A. J Biol Inorg Chem (2008) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem (1977) 36.95
Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev (1972) 19.14
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
Colicins and related bacteriocins. Annu Rev Microbiol (1967) 7.56
LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS. Proc Natl Acad Sci U S A (1964) 7.06
Mechanisms of enzymatic bacteriaolysis. Cell walls of bacteri are solubilized by action of either specific carbohydrases or specific peptidases. Science (1967) 5.14
LYSOSTAPHIN: ENZYMATIC MODE OF ACTION. Biochem Biophys Res Commun (1965) 4.94
Site of initiation of cellular autolysis in Streptococcus faecalis as seen by electron microscopy. J Bacteriol (1970) 2.37
Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans. Proc Natl Acad Sci U S A (1987) 2.02
"Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol (1979) 1.97
Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus. J Bacteriol (1979) 1.46
The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. Appl Environ Microbiol (1995) 1.43
The ins and outs of colicins. Part II. Lethal action, immunity and ecological implications. Microbiol Sci (1984) 1.42
Sequence analysis of a Staphylococcus aureus gene encoding a peptidoglycan hydrolase activity. Gene (1991) 1.26
Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections. Epidemiol Infect (1987) 1.16
Interaction of the staphylococcin-like peptide Pep 5 with cell walls and isolated cell wall components of Gram-positive bacteria. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 1.10
Relatedness and classification of Streptococcus mutans and "mutans-like" streptococci. J Dent Res (1984) 1.05
Bacteriocin-like activity of group B and group C streptococci of human and of animal origin. J Hyg (Lond) (1983) 1.04
Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus. Biochem Biophys Res Commun (1989) 1.04
Ultrastructural and biochemical alterations effected by viridin B, a bacterocin of alpha-hemolytic streptococci. Infect Immun (1976) 1.03
A colorimetric microtiter plate assay for lysostaphin using a hexaglycine substrate. Anal Biochem (1994) 0.97
Spectrophotometric detection of bacteriolytic activity of diluted lysostaphin solutions. Folia Microbiol (Praha) (1993) 0.79
Bacteriocins of gram-positive bacteria. Bacteriol Rev (1976) 10.66
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
"Unruffling" the mystique of therapeutic touch. Nurse Pract (2001) 5.18
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol (1987) 5.03
Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell (1986) 4.56
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Natural infection of Suffolk sheep with scrapie virus. J Infect Dis (1982) 3.42
Pathogenesis of scrapie virus infection in the mouse. J Infect Dis (1967) 3.34
Assay system for bacteriocins. Appl Microbiol (1971) 3.05
Aleutian disease of mink: properties of the etiologic agent and the host responses. J Infect Dis (1968) 3.03
Alternative therapy: a cautionary tale. Nurse Pract (1998) 2.67
Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J (1988) 2.57
Remitting, seronegative, symmetrical synovitis with pitting edema--13 additional cases. J Rheumatol (1990) 2.44
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33
Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA (1985) 2.22
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology (1988) 2.05
Dental caries is a preventable infectious disease. Aust Dent J (2000) 1.98
"Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol (1979) 1.97
Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med (1973) 1.89
Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet Pathol (1980) 1.88
Long lag times and high velocities in the motility of natural assemblages of marine bacteria. Appl Environ Microbiol (1995) 1.86
Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77
Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem (2009) 1.77
Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol (2001) 1.63
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg (1982) 1.62
Bacteriocin of a group B streptococcus: partial purification and characterization. Antimicrob Agents Chemother (1975) 1.59
Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl Environ Microbiol (1993) 1.56
Bacteriocin of a group A streptococcus: partial purification and properties. Antimicrob Agents Chemother (1973) 1.54
Clustering of marine bacteria in seawater enrichments. Appl Environ Microbiol (1996) 1.54
A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol (2006) 1.54
Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol (2000) 1.49
Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science (1983) 1.48
The role of cytosine methylation in the control of nopaline synthase gene expression in a plant tumor. J Mol Appl Genet (1983) 1.48
Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46
Natural assemblages of marine bacteria exhibiting high-speed motility and large accelerations. Appl Environ Microbiol (1995) 1.41
Obstetric fistula in rural Ethiopia. East Afr Med J (2007) 1.38
Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol (1983) 1.38
Course of experimental scrapie virus infection in the goat. J Infect Dis (1974) 1.36
Cloning of the gene encoding Streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence. Appl Environ Microbiol (1993) 1.36
Biotin-avidin-amplified enzyme immunoassay for detection of herpes simplex virus antigen in clinical specimens. J Clin Microbiol (1983) 1.36
Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype. J Exp Med (1984) 1.35
Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys. AIDS Res Hum Retroviruses (1990) 1.29
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29
Relation of the Escherichia coli dnaX gene to its two products--the tau and gamma subunits of DNA polymerase III holoenzyme. Nucleic Acids Res (1987) 1.25
A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun (1994) 1.24
Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis. J Med Microbiol (2000) 1.24
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science (1986) 1.24
Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diagn Lab Immunol (1999) 1.21
Studies on the pressor responses produced by bradykinin and kallidin. Br J Pharmacol Chemother (1968) 1.17
Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections. Epidemiol Infect (1987) 1.16
Application of a modified computer algorithm in determining potential antigenic determinants associated with the AIDS virus glycoprotein. Anal Biochem (1985) 1.15
Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol (2011) 1.13
Novel lantibiotics and their pre-peptides. Antonie Van Leeuwenhoek (1996) 1.12
Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-kappa B binding motifs. EMBO J (1990) 1.12
The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. Clin Exp Immunol (1987) 1.12
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 1. Pyocine typing of Ps. aeruginosa. Med J Aust (1971) 1.12
An inhibitor typing scheme for Streptococcus uberis. J Dairy Res (1986) 1.12
Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. J Immunol (1987) 1.11
Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol (2001) 1.10
Genotypic and phenotypic analysis of Streptococcus uberis isolated from bovine mammary secretions. Epidemiol Infect (1991) 1.09
A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes. Dev Biol Stand (1995) 1.09
Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously. J Virol (1987) 1.08
Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. Science (1984) 1.08
Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis (2008) 1.08
Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity. J Virol (1989) 1.07
Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. J Biol Chem (1987) 1.07
Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. J Med Microbiol (1979) 1.06
Correlation of DNA-anti-DNA association rates with clinical activity in systemic lupus erythematosus (SLE). J Immunol (1981) 1.06
Bacteriocin-like activity of group B and group C streptococci of human and of animal origin. J Hyg (Lond) (1983) 1.04
The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies. J Clin Immunol (1986) 1.04
Royal pastel mink respond variously to inoculation with Aleutian disease virus of low virulence. J Virol (1984) 1.04
Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages. J Med Microbiol (2002) 1.04
Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin. FEMS Microbiol Lett (2000) 1.03
Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 1.03
Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. Arch Oral Biol (1983) 1.03
Factors affecting production of the group A streptococcus bacteriocin SA-FF22. J Med Microbiol (1992) 1.03
Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Res Microbiol (1995) 1.03
HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. J Neuropathol Exp Neurol (2002) 1.03
A chemically defined liquid medium that supports primary isolation of Rochalimaea (Bartonella) henselae from blood and tissue specimens. J Clin Microbiol (1995) 1.03
Epitopes associated with a synthetic hepatitis B surface antigen peptide. J Immunol (1983) 1.02
Genetic basis of streptococcin A-FF22 production. Antimicrob Agents Chemother (1976) 1.02
Detection of interspecies idiotypic cross-reactions associated with antibodies to hepatitis B surface antigen. Eur J Immunol (1983) 1.02
Production and characterization of anti-idiotype reagents for the analysis of viral antigen systems. J Virol Methods (1983) 1.01
Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J Virol (1996) 1.01
A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum (1987) 1.01
Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system. J Virol (1989) 1.01
The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius. Arch Oral Biol (1982) 1.00
Transduction of bacteriocin determinants in group A streptococci. J Exp Med (1976) 0.99
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
Some possible autoimmune mechanisms in rheumatic carditis. Lancet (1972) 0.99
The use of pNJ5000 as an intermediate vector for the genetic manipulation of Agrobacterium Ti-plasmids. J Gen Microbiol (1985) 0.99
Anti-idiotypic antibodies: implications of internal image-based vaccines for infectious diseases. J Infect Dis (1985) 0.98
Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen. Mol Immunol (1998) 0.98
Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius. Microbiology (2011) 0.97
Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus. Antimicrob Agents Chemother (1978) 0.97
Anti-idiotypic antibodies as immunogens: idiotype-based vaccines. Vaccine (1988) 0.97
The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis (2005) 0.97
Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees. J Virol (1990) 0.96